Patent · US Active

Antibody-mediated neutralization of Marburg virus

US10479825B2 · kind B2 · utility

2Cited by
0References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 25, 2016
Grant dateNov 19, 2019
Priority date—
Expiry dateFeb 25, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to antibodies binding to Marburg virus (MARV) glycoprotein (GP) and methods of use therefore.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.